Oracle Stock Climbs Into September 10 Earnings as OpenAI Astra Buzz and Morgan Stanley Lift View

Oracle's pre-earnings rally stretches to a third session

Oracle shares climbed for a third consecutive trading day on Friday, Sept. 4, 2026, as investors positioned ahead of the company's quarterly earnings release scheduled for Sept. 10, 2026. The move extended a recent run-up that market participants tied to product news at a major partner and to fresh analyst commentary on the enterprise software name.

OpenAI GPT 6 "Astra" release cited as a tailwind

Investor's Business Daily reported that Oracle stock was drawing additional support from buzz surrounding OpenAI's release of its GPT 6 "Astra" artificial intelligence model. Oracle's role as an enterprise technology provider to OpenAI-linked workloads has historically made its shares sensitive to product and infrastructure announcements from the AI lab, and IBD framed the Astra launch as a contributing factor to the September rally.

Morgan Stanley lifts price target ahead of the print

Analysts at Morgan Stanley issued a client note on Friday in which they slightly raised their price target on Oracle, according to IBD. The upward revision added to the constructive setup heading into the Sept. 10 report, though IBD did not disclose the new target level or the prior figure in the published excerpt.

Options market pricing an 11% earnings move

Separately, GuruFocus highlighted that Oracle's upcoming earnings report could move the stock by roughly 11%, reflecting implied volatility in the options market around the Sept. 10 release. The figure underscores the magnitude of event risk traders are pricing into the print, even as the shares themselves trade near recent highs.

The Sept. 10 report as the next catalyst

Oracle is set to report quarterly results late in the week of Sept. 7, with IBD specifying a Sept. 10 date. The combination of the OpenAI Astra release, the Morgan Stanley price-target bump and the implied 11% options-driven move frames the print as the central near-term catalyst for the stock.